JPRN-UMIN000034870已完成未知
Double-blind Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza - Double-blind Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza
Kitano Hospital, Tazuke Kofukai Medical Research Institute. Department of Pediatrics0 个研究点目标入组 40 人开始时间: 2018年11月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 15years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients who have suffered from bacterial infection or other viral infection within one week from the start of the study 2)patients who received recipes of Baloxavir marboxil, Oseltamivir, Zanavivir, Laninavir, Peramivir within 4 weeks from the start of the study
研究者
相似试验
尚未招募
不适用
Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with InfluenzaD007251InfluenzaJPRN-jRCT1051180014Kato Kentaro40
已完成
4 期
The 2VAL Study: A trial comparing the effect of valacyclovir and valganciclovir prophylaxis against cytomegalovirus (CMV) infection after renal transplantatioACTRN12610000016033Tomas Reischig, M.D., Ph.D.114
进行中（未招募）
1 期
This trial is designed to determine what effects the human body has on the investigational medicine, ABP 798, and what effects the body has on the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe rheumatoid arthritis (RA). This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.MedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2013-005543-90-DEAmgen Inc300
进行中（未招募）
1 期
This trial is designed to determine the effects the investigational medicine, ABP 798 on the human body , and what effects investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe rheumatoid arthritis (RA).This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.MedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2013-005543-90-EEAmgen Inc300
进行中（未招募）
1 期
This trial is designed to determine the effects the investigational medicine, ABP 798 has on the human body , and what effects the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe rheumatoid arthritis (RA).This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.Rheumatoid arthritisEUCTR2013-005543-90-BGAmgen Inc300